Chicago, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The global in-vitro toxicology testing market was valued at 26.00 billion in 2024 and is expected to reach US$ 57.55 billion by 2033, growing at a CAGR of ...

In the worst-case scenario, getting chemicals in your eyes can lead to blindness. Until now, the eye irritancy potential of chemical substances has had to be assessed using the Draize test on live ...

The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.

In vitro toxicity testing is rapidly being adopted in the pharmaceutical, chemical, and cosmetics industries, for example, as an alternative to animal studies to predict adverse health effects of ...

As the pandemic escalated, in August 2020, the Trump administration Health and Human Services (HHS) directed the Food and Drug Administration (FDA) to stop requesting premarket approval for clinical ...

On October 3, 2024, the WHO approved the first mpox in vitro diagnostic through its Emergency Use Listing procedure. According to the organization's press release, this approval marks a move toward ...

In a recent study posted to the bioRxiv* preprint server, researchers developed a novel in vitro model that expresses the angiotensin-converting enzyme 2 (ACE-2) receptor from seven bar species in a ...

An in vitro study found that a self-emulsifying anhydrous suspension vehicle achieved over 90 percent drug recovery, low ...

Scientists engineered an HVEM-derived peptide that blocked about sixty percent of HSV-1 infection in cell tests without ...